Search

everythinglearnresearchcommunity

for

Search:↓

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Hydroxychloroquine may help treat alopecia areata in children.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Different treatments for alopecia areata have unpredictable results and varying success rates.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Laminaria japonica and Cistanche tubulosa extracts combined may effectively promote hair growth.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.